Follow Topic:

Health Policy and Reform

perspective

Strategic envy may have an appropriate place in health policy. For instance, for the United Kingdom and the United States, a focus on the most positive aspects of each country’s health care system may provide solutions to the other country’s challenges.

  • Free Full Text
Reevaluating 'Made in America' -- Two Cost-Containment Ideas from Abroad
perspective

Two cost-containment pricing strategies from abroad could be adapted to the U.S. health care context: a bundled-payment system from Germany and volume-driven pricing adjustment from Japan. These promising policies would not require large-scale reform.

  • Free Full Text
perspective
Published Online: April 17, 2013

Many local law-enforcement agencies in the United States ask physicians to assess the physical and mental competence of applicants for concealed-weapons permits. But physicians may have legal and ethical concerns, and we lack standards for making these determinations.

  • Free Full Text
  • Audio Interview
New Evidence about an Old Drug -- Risk with Codeine after Adenotonsillectomy
perspective
Published Online: April 24, 2013

In response to reports of respiratory depression and death in young children who had received codeine after tonsillectomy, adenoidectomy, or both, the FDA initiated a safety evaluation. The result is a boxed warning on the labels of all codeine-containing products.

  • Free Full Text

featured multimedia

Physicians and Gun Violence
Physicians and Gun Violence
  • Audio Interview

Data Watch

Medicare Expenditures as Percentage of GDP

Health Spending Growth, Actual vs. Predicted

Showing 1 to 20 of 1408 Articles

Sort By:

  • Perspective

    Shortly after the shootings in Newtown, Connecticut, two of us received letters from our county sheriff in North Carolina asking whether one of our patients had medical or physical conditions that would preclude issuance of a permit to carry a concealed weapon. Uncomfortable with our limited…

    • June 13, 2013
    • Goldstein A.O.Barnhouse K.K.Viera A.J.Tulsky J.A.Richman B.D.
    • N Engl J Med 2013; 368:2251-2253
    • Free Full Text
    • Audio

    Many local law-enforcement agencies in the United States ask physicians to assess the physical and mental competence of applicants for concealed-weapons permits. But physicians may have legal and ethical concerns, and we lack standards for making these determinations.

  • Sounding Board

    The investment in health services in low- and middle-income countries has increased substantially in recent years. Such investment has been led by unprecedented efforts to combat major diseases, enabled by the availability of lower-cost and effective drug regimens for treatment and prophylaxis,…

    • June 13, 2013
    • Jani I.V. and Peter T.F.
    • N Engl J Med 2013; 368:2319-2324

      In areas of limited resources, point-of-care diagnostic testing is being increasingly used to identify disease, determine prognosis, and monitor treatment. Investments in new diagnostics are starting to improve care. Health systems need to evolve to reap benefits for global health.

    • Perspective

      Aristotle saw envy as "the pain caused by the good fortune of others." Medieval theologians considered it a deadly sin, and in Dante's purgatory, the envious had their eyes sewn shut. Nevertheless, we believe that envy has an appropriate place in health policy, if in this case it means health…

      • June 13, 2013
      • Seddon N. and Lee T.H.
      • N Engl J Med 2013; 368:2245-2247
      • Free Full Text

      Strategic envy may have an appropriate place in health policy. For instance, for the United Kingdom and the United States, a focus on the most positive aspects of each country's health care system may provide solutions to the other country's challenges.

    • Perspective

      Per capita spending on health care in the United States is more than double that in most other high-income, highly industrialized countries (see graph), yet performance on indicators of health status is often worse. The Institute of Medicine recently reported that there is a "strikingly persistent…

      • June 13, 2013
      • Anderson G.F.Willink A.Osborn R.
      • N Engl J Med 2013; 368:2247-2249
      • Free Full Text

      Two cost-containment pricing strategies from abroad could be adapted to the U.S. health care context: a bundled-payment system from Germany and volume-driven pricing adjustment from Japan. These promising policies would not require large-scale reform.

    • Original Article

      Most studies suggest that intensivist physicians improve patient outcomes in intensive care units (ICUs).– It is thus tempting to conclude that a "dose–response effect" might exist, such that greater exposure to intensivists would be associated with even better outcomes. Indeed, some authors…

      • June 6, 2013
      • Kerlin M.P., Small D.S., Cooney E., et al.
      • N Engl J Med 2013; 368:2201-2209

        In this single-center, controlled trial at a U.S. academic medical center, investigators found that having in-house intensivists available at night did not have a significant effect on the length of stay in the ICU.

      • Review Article

        Just over three decades ago, a new outbreak of opportunistic infections and Kaposi's sarcoma was reported in a small number of homosexual men in California and New York. This universally fatal disease, which was eventually called the acquired immunodeficiency syndrome (AIDS), was associated with a…

        • June 6, 2013
        • Piot P. and Quinn T.C.
        • N Engl J Med 2013; 368:2210-2218
        • Free Full Text
        • CME
        • Interactive/Multimedia

        The HIV–AIDS pandemic is now in its fourth decade. This article describes how HIV–AIDS has been transformed from a death sentence into a manageable illness and outlines the need for continued and coordinated international efforts.

      • Perspective

        During the past 10 years, efforts in pharmacogenomics have generated insights into the efficacy and safety of drugs, enhancing our understanding of the safety profile of even some of the oldest drugs, such as codeine sulfate, an opioid analgesic first approved in 1950 for relief of mild or moderate…

        • June 6, 2013
        • Racoosin J.A.Roberson D.W.Pacanowski M.A.Nielsen D.R.
        • N Engl J Med 2013; 368:2155-2157
        • Free Full Text

        In response to reports of respiratory depression and death in young children who had received codeine after tonsillectomy, adenoidectomy, or both, the FDA initiated a safety evaluation. The result is a boxed warning on the labels of all codeine-containing products.

      • Perspective

        Over the past half-century, historians have used episodes of epidemic disease to investigate scientific, social, and cultural change. Underlying this approach is the recognition that disease, and especially responses to epidemics, offers fundamental insights into scientific and medical practices,…

        • June 6, 2013
        • Brandt A.M.
        • N Engl J Med 2013; 368:2149-2152
        • Free Full Text
        • Audio

        The changes wrought by HIV have affected research, clinical practice, and policy. And the AIDS epidemic provided the foundation for a revolution that upended traditional approaches to “international health,” replacing them with innovative global approaches to disease.

      • PerspectiveOnline First

        Each year in the United States, nearly 500,000 infants — 1 in every 8 — are born prematurely, before 37 weeks of gestation. Despite substantial advances in their care, premature infants face a daunting array of challenges; they are at high risk for death in infancy and face severe and lifelong…

        • June 5, 2013
        • Hudson K.L.Guttmacher A.E.Collins F.S.
        • 10.1056/NEJMp1306986
        • Free Full Text
      • CorrespondenceOnline First

        To the Editor: We are a group of scholars and leaders in bioethics and pediatrics with extensive experience in ethical and regulatory issues in pediatrics and human subjects research. We urge the Office for Human Research Protections (OHRP) to withdraw its notification to the institutions involved…

        • June 5, 2013
        • 10.1056/NEJMc1307008
        • Free Full Text

        To the Editor: We are a group of scholars and leaders in bioethics and pediatrics with extensive experience in ethical and regulatory issues in pediatrics and human subjects research. We urge the Office for Human Research Protections (OHRP) to withdraw ...

      • Special Article

        In 2009, more than one quarter of adults in the United States between the ages of 18 and 34 years had no health insurance coverage. There are several reasons for this. First, many young adults enter the workforce in relatively low-paying positions that do not include the offer of health insurance,…

        • May 30, 2013
        • Mulcahy A., Harris K., Finegold K., et al.
        • N Engl J Med 2013; 368:2105-2112

          The Affordable Care Act extended the age of eligibility for dependent coverage under parents' health insurance to 26 years. This analysis of claims data showed that after implementation of the provision, young adults requiring emergency care were less likely to be uninsured.

        • Clinical Decisions

          Readers recently joined in a lively debate about the use of medicinal marijuana. In Clinical Decisions, an interactive feature in which experts discuss a controversial topic and readers vote and post comments, we presented the case of Marilyn, a 68-year-old woman with metastatic breast cancer. We…

          • May 30, 2013
          • Adler J.N. and Colbert J.A.
          • N Engl J Med 2013; 368:e30
          • Free Full Text

          In February, we invited you to share your opinion about the medicinal use of marijuana. We now present the polling results.

        • Perspective

          The new Physician Payments Sunshine Act requires public reporting of payments to physicians and teaching hospitals from pharmaceutical and medical device companies, as well as reporting of certain ownership interests (see box). Sponsored by Senators Charles Grassley (R-IA) and Herb Kohl (D-WI) and…

          • May 30, 2013
          • Agrawal S.Brennan N.Budetti P.
          • N Engl J Med 2013; 368:2054-2057
          • Free Full Text

          Under the Physician Payments Sunshine Act, drug and device manufacturers and group purchasing organizations will report to the Centers for Medicare and Medicaid Services payments made to physicians and teaching hospitals, and the data will be posted on a public website.

        • Perspective

          Financial relationships between pharmaceutical manufacturers and health care professionals remain controversial. Some interactions, such as those involving research and exchange of expertise, promote the development and study of new drugs; by contrast, payments in the form of meals and continuing…

          • May 30, 2013
          • Kesselheim A.S.Robertson C.T.Siri K.Batra P.Franklin J.M.
          • N Engl J Med 2013; 368:2049-2052
          • Comments

          Massachusetts now requires drug and device manufacturers to report payments they make to physicians or teaching hospitals. The first 30 months' worth of data included 32,227 reported payments to 11,734 Massachusetts physicians, for a total of $76.7 million.

        • Perspective

          After extensive public comment, the Centers for Medicare and Medicaid Services (CMS) issued final regulations in February implementing the Physician Payments Sunshine Act, enacted as part of the Affordable Care Act. The 287-page document details requirements for producers of drugs, biologics,…

          • May 30, 2013
          • Rosenthal M.B. and Mello M.M.
          • N Engl J Med 2013; 368:2052-2054
          • Free Full Text
          • Audio
          • Comments

          Will new rules requiring drug and device companies to disclose payments to physicians and teaching hospitals have the intended effects? Disclosure's benefits are unlikely to be realized without the activation of “learned intermediaries,” such as health insurers.

        • PerspectiveOnline First

          Controversy has followed the Independent Payment Advisory Board (IPAB) since its inception. The Affordable Care Act (ACA) established the IPAB as a 15-member, nonelected board. Among other duties, the IPAB is empowered to recommend changes to Medicare if projected per-beneficiary spending growth…

          • May 29, 2013
          • Oberlander J. and Morrison M.
          • 10.1056/NEJMp1306051
          • Free Full Text

          Controversy has followed the Independent Payment Advisory Board (IPAB) since its inception. The Affordable Care Act (ACA) established the IPAB as a 15-member, nonelected board. Among other duties, the IPAB is empowered to recommend changes to Medicare if ...

        • Sounding Board

          In March 2012, the Society of General Internal Medicine convened the National Commission on Physician Payment Reform to recommend forms of payment that would maximize good clinical outcomes, enhance patient and physician satisfaction and autonomy, and provide cost-effective care. The formation of…

          • May 23, 2013
          • Schroeder S.A. and Frist W.
          • N Engl J Med 2013; 368:2029-2032
          • Free Full Text
          • Comments

          The National Commission on Physician Payment Reform recommends phasing out fee-for-service and outlines strategies to change the model during the transition. The commission advises revision of fee schedules so that evaluation and management are valued as highly as procedures.

        • Perspective

          On April 15, two improvised explosive devices (IEDs) were detonated in short succession near the finish line of the Boston Marathon, in the middle of a densely packed crowd of thousands of runners, families, friends, and spectators. Three people were killed and 264 were injured, with more than 20…

          • May 23, 2013
          • Biddinger P.D., Baggish A., Harrington L., et al.
          • N Engl J Med 2013; 368:1958-1960
          • Free Full Text
          • Comments

          The fact that there was not more loss of life in the Boston Marathon bombings is attributable in large part to the medical community's prior efforts to build and sustain emergency-preparedness programs and to practice its response in exercises and drills.

        • Perspective

          At 2:50 p.m. on April 15, nearly 3 hours after the first runner completed the Boston Marathon, two blasts ripped through the crowd that was gathered along the approach to the finish line, killing 3 people and injuring more than 260. Within moments, the crowd's initial panic was replaced by…

          • May 23, 2013
          • Kellermann A.L. and Peleg K.
          • N Engl J Med 2013; 368:1956-1957
          • Free Full Text
          • Audio
          • Comments

          The Boston Marathon bombing and the medical response offer several important lessons, including that the remarkably low mortality rate (1%) was attributable in part to several factors favoring the rescuers and that disaster preparedness still requires planning.

        • Perspective

          As we say in the U.S. Navy, "We train like we fight, and we fight like we train." In Boston, we do the same. That was never more evident than at 2:50 p.m. on April 15, when two explosive devices abruptly shattered the 117th Boston Marathon. On Patriot's Day, the day we commemorate the opening…

          • May 23, 2013
          • Goralnick E. and Gates J.
          • N Engl J Med 2013; 368:1960-1961
          • Free Full Text
          • Comments

          In recent years, Brigham and Women's Hospital has activated its emergency response team for many drills that taught staff familiarity, comfort, trust, and routines during a disaster. After the Boston Marathon bombing, when the hospital treated 39 survivors, routines saved lives.

        Page

        Health Policy Briefs

        Jun 12, 2013
        Pediatric Lung-Transplant Controversy

        The Organ Procurement and Transplantation Network (OPTN) made headlines over the past week as legislators, high-level officials, courts, and a media campaign weighed in on the cases of Sarah Murnaghan and Javier Acosta — children younger than 12 who have end-stage cystic fibrosis and need lung transplants. The debate concerns OPTN’s “Under 12” rule (Policy 3.7), which delineates a separate process for allocating lungs to transplantation candidates who are 0 to 11 years of age, first prioritizing children for a limited pool of lungs from child donors (as versus the somewhat-more-available adult lungs). A federal court ruling called the rule “arbitrary, capricious, and an abuse of discretion” and allowed Murnaghan and Acosta to be placed on the waiting list for adult lung transplants and treated similarly to older candidates. On June 10, OPTN convened an emergency executive session and ordered a review of the Under 12 rule; in the interim, it will allow sick children in need of lungs to have their cases reviewed by an expert panel.

        Jun 12, 2013
        Consumer Cost Savings from Medical Loss Ratio

        In 2012, the Medical Loss Ratio (MLR) provision of the Affordable Care Act saved consumers approximately $2.1 billion, mostly in the form of reduced premiums, according to the Kaiser Family Foundation. The provision requires insurers to spend a certain percentage of their enrollees’ premiums on health care services and quality-improvement efforts, thereby limiting the portion that can be retained in profits or spent on administration and marketing. Insurers who do not meet the benchmarks must issue rebates to their enrollees; such rebates amounted to an estimated $1.1 billion last year.  Since the majority of savings are thought to be from premium reductions rather than rebates, however, the report noted: “Perhaps ironically, when the MLR provision is working as intended and insurers set premiums to meet the thresholds, consumers save money but are less likely to get a check in the mail as tangible demonstration of those savings.”

        Jun 12, 2013
        Loosening Rosiglitazone Restrictions?

        A joint advisory committee to the Food and Drug Administration has recommended that the agency ease restrictions on the diabetes drug rosiglitazone (Avandia). Sales of the former blockbuster drug began to markedly decline in 2007 after safety concerns were widely publicized. The FDA pulled rosiglitazone from pharmacy shelves in 2010, after data suggested that patients who took it had elevated cardiovascular risk. Even if marketing restrictions are lifted, prospects for widespread prescribing may be dim, since only 3400 people in the United States reportedly still take rosiglitazone (now available only through a special registry) and its patent expired in 2011. The drug’s manufacturer, GlaxoSmithKline, says that it continues “to believe that Avandia is a safe and effective treatment option for type 2 diabetes when used for the appropriate patient and in accordance with labeling” and that it will work with the FDA as its considers the committee’s recommendation.

        Jun 05, 2013
        Solvency of Medicare Trust Fund Extended

        In its 2013 annual report, Medicare’s board of trustees indicates that Medicare’s hospital insurance (Part A) trust fund will remain solvent until 2026. As of last year’s annual report, the trust fund was expected to be exhausted 2 years earlier. The new projections are based on current law, including the implementation of cuts to physician payments dictated by the sustainable growth rate formula and the approximately 165 provisions of the Affordable Care Act related to the financing and delivery of Medicare services. The updated projection should therefore not be read as the trustees’ “most likely expectations of actual Medicare financial operations,” notes the board, but rather as “illustrations of the very favorable impact of permanently slower growth in health care costs.”  The report calls for “timely and effective action” to resolve the financial challenges plaguing Medicare, which currently has more than 50 million enrollees and spent more than $574 billion in 2012.

        Jun 05, 2013
        Rule on Workplace Wellness Programs Finalized

        Last week, the Obama administration released its final rule for workplace wellness programs. Updating the relevant 2006 regulations, the rule enhances employers’ ability to provide incentives to their employees for engaging in healthy behavior. Wellness
        programs can be either participatory — providing no reward for performance (for example, an offer of a free gym membership) — or health-contingent — rewarding
        employees with reductions in the cost of their health insurance premiums for completing
        an activity such as participation in a walking program or achieving a particular health outcome, such as quitting smoking.  Concurrent with the rule’s release, RAND
        issued a report on the current state of wellness programs, stating that approximately half of all employers with more than 50 employees offer some type of wellness program, which “can help contain the current epidemic of lifestyle-related diseases.”

        Jun 05, 2013
        Immigration and Health Care

        On May 21, the Senate Judiciary Committee passed a bill (S.744) that would provide a
        pathway for citizenship for 11 million undocumented immigrants. It is expected to come before the full Senate next week. Before the committee’s action, the possibility of expanding the benefits of health care reform to undocumented immigrants had been taken off the table as part of a bipartisan effort to keep immigration reform alive. At the same time, House Republicans are tinkering with legislation that would require undocumented immigrants to obtain health insurance before gaining full citizenship status. Some observers have noted the political complications faced by such a move, drawing parallels between the proposal and the ACA’s individual mandate to obtain insurance coverage, which the GOP-led House has strongly opposed and voted to repeal yet again on May 16.  Meanwhile, a new report reveals that between 2002 and
        2009, immigrants paid $115 billion more into Medicare than the program paid for
        their medical expenses.

        May 29, 2013
        Contraceptive-Coverage Mandate Reaches Appeals Courts

        Last week, a number of appellate courts, including the 7th Circuit Court of Appeals, heard oral arguments related to the Affordable Care Act (ACA) provision requiring employers to cover (without cost sharing) certain preventive care, including FDA-approved contraceptive methods. Some nonprofit religious groups were afforded an exemption last year from fulfilling these requirements by the August 2012 deadline. Now, some for-profit employers, including the Oklahoma-based crafts-store chain Hobby Lobby and Grote Industries of Indiana, are seeking a similar exemption from the contraception-coverage mandate, contending that it conflicts with their religious beliefs. Many observers expect that one of the approximately 59 challenges to this mandate, which assert that it violates a variety of constitutional rights as well as the Religious Freedom Restoration Act, will eventually make its way to the Supreme Court.

        May 29, 2013
        Glycated Hemoglobin Test Approved for Diagnosing Diabetes

        As of May 23, health care professionals can use the Cobas Integra 800 Tina-quant HbA1cDx assay (Roche) to diagnose diabetes, which affects an estimated 25.8 million people in the United States. Although other glycated hemoglobin tests have been on the market for monitoring blood glucose and have been used unofficially for diabetes diagnosis, this is the first product to receive FDA approval to be marketed for the purpose of diagnosing the disease. Alberto Gutierrez of the FDA’s Center for Devices and Radiological Health remarked that “providing health care professionals with another tool to identify undiagnosed cases of diabetes should help them provide patients appropriate guidance on treatment before problems develop.”

        May 29, 2013
        Covered California Announces Insurers, Proposed Rates

        As states continued to prepare for the January 1, 2014, deadline for launching their health insurance exchanges, California, the country’s most populous state, announced last week which insurers would be participating in its exchange and the expected premiums for individuals enrolling in their plans. Nearly three dozen insurers submitted bids to provide health coverage through Covered California — the state’s exchange that will operate as a one-stop shop for the 5.3 million Californians expected to receive federal subsidies to purchase health insurance — and 13 were selected.  Exchange leaders touted the rates proposed for the individual market as a “home run for consumers in every region of California.”  Consumers Union (the policy and action division of Consumer Reports) praised the exchange’s move, stating that its publicizing of this information “will make it dramatically easier for consumers to compare plans and make smart choices that fit their budget.”

        May 22, 2013
        Tavenner Confirmed as CMS Administrator

        On Wednesday, May 15, on 91-to-7 vote, Marilyn Tavenner became the first Senate-confirmed administrator of the Centers for Medicare and Medicaid Services since 2006. Tavenner has been serving as acting administrator of the $800 billion agency since December 2011, when her predecessor, Don Berwick, resigned after it became clear that Senate confirmation was politically infeasible. Though Tavenner enjoyed a rare level of bipartisan support throughout the nomination process, her confirmation was unexpectedly delayed by Senator Tom Harkin (D-IA) because of his concerns about the redirection of funding from prevention efforts to implementation of health care reform. The American Medical Association was among the many groups that applauded Tavenner’s confirmation, expressing its intent to “work with the administrator to strengthen the Medicare system to improve health outcomes for patients and the practice environment for physicians.”

        Medical Meetings Emergency Medicine Conferences and Meetings

        A Primary Care Guide To Emergencies

        The conference will be held in London, Dec. 28 and 29.

        Contact Pascale Anthone, Medical-Credits, Heide 29, 2235 Westmeerbeek, Belgium; or call (32) 16438402; or e-mail info@medical-credits.com; or see http://www.medical-credits.com .

        More Medical Meetings

        Trends

        Health Policy and Reform

        Most Viewed (Last Week)